kenneth j gorelick md fccp executive profile  biography  bloomberg july    pm et biotechnology company overview of neurotrope inc snapshotpeople  overviewboard memberscommittees executive profile kenneth j gorelick md fccpchief medical officer and director neurotrope incagetotal calculated compensationthis person is connected to  board members in  different organizations across  different industriessee board relationships background dr kenneth j gorelick also known as ken md fccp serves as the managing director of zymo consulting group llc dr gorelick has been president and chief executive officer of zymo consulting group llc since  dr gorelick has been chief medical officer of neurotrope inc since february   dr gorelick has been venture partner of ngn capital since  and ngn biomed opportunity i lp dr gorelick serves as the chief operating officer of enzybiotics  llc and served as its president and chief executive officer from  to  he serves as chief medical officer for pin pharma he has been the chief development officer of pin pharma since may  where he is responsible for drug development activity of novel immunostimulatory anticancer agents dr gorelick is a consultant to the biopharmaceutical industry he consults to pfizer as clinical lead of a global development program dr gorelick has provided consulting services to pfizer shire pin pharma and ngn capital among others dr gorelick has expertise with numerous approvals of blas ndas and maas prior to these assignments he served as the vice president of global clinical research and development at dupont merck research laboratories inc and dupont pharmaceuticals from  to  he was a consultant at wyeth research from  to  and senior vice president  cmo of pharmaprint from  to  dr gorelick served as the vice president of drug development and chief medical officer at genelabs technologies inc from  to  he served as director of clinical research at xoma from  to  he serves as the chairman of advisory board of asahi kasei pharma america corporation he serves as a member of scientific advisory board at cynvec llc he has been a director of neurotrope inc since august   he serves as a director of neurotrope bioscience he is a fellow of the american college of chest physicians he was a clinical associate professor of medicine at stanford university until  where he previously completed his fellowship in pulmonary disease and more recently was adjunct faculty at rockefeller university dr gorelick is board certified in internal medicine and pulmonary diseases he has  years of experience in the development of drugs and biologics and medical devices in the human health care sector dr gorelick holds a md from weill cornell medical college of cornell university and a bs from the state university of new york at buffalo he completed postdoctoral training at st louis university and stanford university he completed a residency in internal medicine at st louis universityread full background corporate headquarters  east nd streetnew york new york united statesphone fax  board members memberships presentchief medical officer and directorneurotrope inc education bs university at buffalomd weill cornell medical college new york other affiliations university at buffalongn capitalngn biomed opportunity i lpasahi kasei pharma america corporationweill cornell medical college new yorkcynvec llc annual compensation there is no annual compensation data available stocks options there is no stock options data available total compensation total annual cash compensationtotal calculated compensation request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup competitor compensationthere is no competitor compensation data available sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact neurotrope inc please visit  company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft our records indicate this provider may no longer be practicing kenneth j gorelick search for similar providers in mountain view ca critical care medicine you may be trying to access this site from a secured browser on the server please enable scripts and reload this page journal logo secondary logo account saved searches recent searches register activate subscription login subscribe help you currently have no recent searches enter your email address wolters kluwer health may email you for journal alerts and information but is committed to maintaining your privacy and will not share your personal information without your express consent for more information please refer to our privacy policy subscribe to etoc   home  transplantation direct current issue august   volume   issue  editorinchief timothy g buchman phd md mccm issn  online issn  frequency  issues  year ranking critical care medicine  impact factor  subscribe to etoc featured supplement december   volume   supplement   published december  other supplements december   volume   supplement  the th critical care congress abstract supplementpublished december  december   volume   supplement  the th critical care congress abstract supplementpublished december  december   volume   supplement  the rd critical care congress abstract supplementpublished december  september   volume   supplement  creating and implementing the  icu pain agitation and delirium guidelines for adult icu patientsrnpublished september  add items to   an existing folder a new folder folder name description the items has been successfully added to  email to a colleague colleagues email is invalid your name optional your email colleagues email separate multiple emails with a  message thought you might appreciate this items i saw at critical care medicine send a copy to your email your message has been successfully sent to your colleague some error has occurred while processing your request please try after some time export to end note procite reference manager save my selection current issue highlights guest foreword is early goaldirected therapy harmful to patients with sepsis and high disease severity kalil andre c kellum john a kalil andre c kellum john a less critical care medicine   august   favorites pdf request permissions feature articles antibiotic therapy in comatose mechanically ventilated patients following aspiration differentiating pneumonia from pneumonitis lascarrou jean baptiste lissonde floriane le thuaut aurélie more lascarrou jean baptiste lissonde floriane le thuaut aurélie bachoumas konstantinos colin gwenhael henry lagarrigue matthieu vinatier isabelle fiancette maud lacherade jean claude yehia aihem joret aurélie lebert christine bourdon sandra martin lefèvre laurent reignier jean less critical care medicine   august  abstract abstract abstract go to full text of this article  favorites pdf request permissions clinical investigations preoperative cognitive performance and postoperative delirium are independently associated with future dementia in older people who have undergone cardiac surgery a longitudinal  lingehall helena claesson smulter nina s lindahl elisabeth more lingehall helena claesson smulter nina s lindahl elisabeth lindkvist marie engström karl gunnar gustafson yngve g olofsson birgitta less critical care medicine   august  abstract abstract abstract go to full text of this article  favorites pdf request permissions neurologic critical care hyperchloremia is associated with acute kidney injury in patients with subarachnoid hemorrhage sadan ofer singbartl kai kandiah prem a more sadan ofer singbartl kai kandiah prem a martin kathleen s samuels owen b less critical care medicine   august  abstract abstract abstract  favorites pdf request permissions pediatric critical care abusive head trauma and mortality–an analysis from an international comparative effectiveness study of children with severe traumatic brain injury miller ferguson nikki sarnaik ajit miles darryl more miller ferguson nikki sarnaik ajit miles darryl shafi nadeem peters mark j truemper edward vavilala monica s bell michael j wisniewski stephen r luther james f hartman adam l kochanek patrick m for the investigators of the approaches and decisions in acute pediatric traumatic brain injury adapt trial less critical care medicine   august  abstract abstract abstract  favorites pdf request permissions editorials distinguishing pneumonia from pneumonitis to safely discontinue antibiotics rimawi ramzy husam rimawi ramzy husam less critical care medicine   august   favorites pdf request permissions online clinical investigations both positive and negative fluid balance may be associated with reduced longterm survival in the critically ill balakumar vikram murugan raghavan sileanu florentina e more balakumar vikram murugan raghavan sileanu florentina e palevsky paul clermont gilles kellum john a less critical care medicine  ee august  abstract abstract abstract  favorites pdf request permissions online laboratory investigations sequential analysis of a panel of biomarkers and pathologic findings in a resuscitated rat model of sepsis and recovery arulkumaran nishkantha sixma marije l jentho elisa more arulkumaran nishkantha sixma marije l jentho elisa ceravola elias bass paul s kellum john a unwin robert j tam fred w k singer mervyn less critical care medicine  ee august  abstract abstract abstract go to full text of this article  favorites pdf request permissions online review article effects of polymyxin b hemoperfusion on mortality in patients with severe sepsis and septic shock a systemic review metaanalysis update and disease severity subgroup chang tzu tu yukang lee chentse more chang tzu tu yukang lee chentse chao anne huang chihsiang wang mingjiuh yeh yuchang less critical care medicine  ee august  abstract abstract abstract go to full text of this article  favorites pdf request permissions online case reports lower cranial nerves paralysis following proneposition mechanical ventilation trejogabrielgalan jose m perearodriguez maria eugenia aicuarapun irene more trejogabrielgalan jose m perearodriguez maria eugenia aicuarapun irene martinezbarrio esther less critical care medicine  ee august  abstract abstract abstract  favorites pdf request permissions online letters to the editor obesity survival paradox in the critically ill pepper dominique j pepper dominique j less critical care medicine  e august   favorites pdf request permissions table of contents sections guest foreword feature articles clinical investigations neurologic critical care pediatric critical care editorials online clinical investigations online laboratory investigations online review article online case reports online letters to the editor most popular most viewed most emailed highest impact surviving sepsis campaign international guidelines for a users’ guide to the  surviving sepsis guidelines is early goaldirected therapy harmful to patients with antibiotic therapy in comatose mechanically ventilated american college of critical care medicine clinical view all most viewed most emailed highest impact editors choice is early goaldirected therapy harmful to patieantibiotic therapy in comatose mechanically venrepeated critical illness and unplanned readmisclinical experience with iv angiotensin ii admidistinguishing pneumonia from pneumonitis to sa view all society of critical care medicine members can access the full content of critical care medicine using a single login at mysccm   listen to the sccm icritical care podcasts nih public access policy critical care medicine is compliant with funding agency requirements for nih public access for more complete information please review the nih public access policy featured jobs view all featured jobs search jobs now keywords zippostal code within  miles  miles  miles  miles  miles  miles  miles  miles powered by official statement of the society of critical care medicine ​recommendations for achieving and maintaining competence and credentialing in critical care ultrasound with focused cardiac ultrasound and advanced critical care echocardiography current issue  critical care medicine you may be trying to access this site from a secured browser on the server please enable scripts and reload this page journal logo secondary logo account saved searches recent searches register activate subscription login subscribe help you currently have no recent searches enter your email address wolters kluwer health may email you for journal alerts and information but is committed to maintaining your privacy and will not share your personal information without your express consent for more information please refer to our privacy policy subscribe to etoc   home  current issue  previous issue august   volume   issue  pp ee table of contents outline subscribe to etoc view contributor index add items to   an existing folder a new folder folder name description the items has been successfully added to  email to a colleague colleagues email is invalid your name optional your email colleagues email separate multiple emails with a  message thought you might appreciate this items i saw at critical care medicine send a copy to your email your message has been successfully sent to your colleague some error has occurred while processing your request please try after some time export to end note procite reference manager save my selection guest foreword is early goaldirected therapy harmful to patients with sepsis and high disease severity kalil andre c kellum john a kalil andre c kellum john a less critical care medicine   august   favorites pdf request permissions feature articles antibiotic therapy in comatose mechanically ventilated patients following aspiration differentiating pneumonia from pneumonitis lascarrou jean baptiste lissonde floriane le thuaut aurélie more lascarrou jean baptiste lissonde floriane le thuaut aurélie bachoumas konstantinos colin gwenhael henry lagarrigue matthieu vinatier isabelle fiancette maud lacherade jean claude yehia aihem joret aurélie lebert christine bourdon sandra martin lefèvre laurent reignier jean less critical care medicine   august  abstract abstract abstract go to full text of this article  favorites pdf request permissions repeated critical illness and unplanned readmissions within  year to picus edwards jeffrey d lucas adam r boscardin w john more edwards jeffrey d lucas adam r boscardin w john dudley r adams less critical care medicine   august  abstract abstract abstract go to full text of this article  favorites pdf request permissions clinical experience with iv angiotensin ii administration a systematic review of safety busse laurence w wang xueyuan shelly chalikonda divya m more busse laurence w wang xueyuan shelly chalikonda divya m finkel kevin w khanna ashish k szerlip harold m yoo david dana sharon l chawla lakhmir s less critical care medicine   august  abstract abstract abstract go to full text of this article  favorites pdf request permissions clinical investigations preoperative cognitive performance and postoperative delirium are independently associated with future dementia in older people who have undergone cardiac surgery a longitudinal  lingehall helena claesson smulter nina s lindahl elisabeth more lingehall helena claesson smulter nina s lindahl elisabeth lindkvist marie engström karl gunnar gustafson yngve g olofsson birgitta less critical care medicine   august  abstract abstract abstract go to full text of this article  favorites pdf request permissions recommendations for methicillinresistant staphylococcus aureus prevention in adult icus a costeffectiveness analysis whittington melanie d atherly adam j curtis donna j more whittington melanie d atherly adam j curtis donna j lindrooth richard c bradley cathy j campbell jonathan d less critical care medicine   august  abstract abstract abstract  favorites pdf request permissions should all massively transfused patients be treated equally an analysis of massive transfusion ratios in the nontrauma setting etchill eric w myers sara p mcdaniel lauren m more etchill eric w myers sara p mcdaniel lauren m rosengart matthew r raval jay s triulzi darrell j peitzman andrew b sperry jason l neal matthew d less critical care medicine   august  abstract abstract abstract  favorites pdf request permissions nonlinear imputation of paofio from spofio among mechanically ventilated patients in the icu a prospective observational study brown samuel m duggal abhijit hou peter c more brown samuel m duggal abhijit hou peter c tidswell mark khan akram exline matthew park pauline k schoenfeld david a liu ming grissom colin k moss marc rice todd w hough catherine l rivers emanuel thompson b taylor brower roy g for the national institutes of health nihnational heart lung and blood institute nhlbi prevention and early treatment of acute lung injury pet less critical care medicine   august  abstract abstract abstract  favorites pdf request permissions organizational issues structure and processes of care in  icus in latin america a study from the latin america intensive care network estenssoro elisa alegría leyla murias gastón more estenssoro elisa alegría leyla murias gastón friedman gilberto castro ricardo nin vaeza nicolas loudet cecilia bruhn alejandro jibaja manuel ospinatascon gustavo ríos fernando machado flavia r biasi cavalcanti alexandre dubin arnaldo hurtado f javier briva arturo romero carlos bugedo guillermo bakker jan cecconi maurizio azevedo luciano hernandez glenn on behalf of the latinamerican intensive care network liven less critical care medicine   august  abstract abstract abstract  favorites pdf request permissions dysglycemia glycemic variability and outcome after cardiac arrest and temperature management at °c and °c borgquist ola wise matt p nielsen niklas more borgquist ola wise matt p nielsen niklas alsubaie nawaf cranshaw julius cronberg tobias glover guy hassager christian kjaergaard jesper kuiper michael smid ondrej walden andrew friberg hans for the ttmtrial investigators less critical care medicine   august  abstract abstract abstract  favorites pdf request permissions impact of telemedicine monitoring of community icus on interhospital transfers pannu jasleen sanghavi devang sheley todd more pannu jasleen sanghavi devang sheley todd schroeder darrell r kashyap rahul marquez alberto daniels craig e brown daniel r caples sean m less critical care medicine   august  abstract abstract abstract  favorites pdf request permissions using qualitative research to inform development of professional guidelines a case study of the society of critical care medicine familycentered care guidelines coombs maureen a davidson judy e nunnally mark e more coombs maureen a davidson judy e nunnally mark e wickline mary a curtis j randall less critical care medicine   august  abstract abstract abstract  favorites pdf request permissions extracorporeal membrane oxygenation for acute decompensated heart failure dangers laurence bréchot nicholas schmidt matthieu more dangers laurence bréchot nicholas schmidt matthieu lebreton guillaume hékimian guillaume nieszkowska ania besset sébastien trouillet jeanlouis chastre jean leprince pascal combes alain luyt charlesedouard less critical care medicine   august  abstract abstract abstract  favorites pdf request permissions the utility of highfidelity simulation for training critical care fellows in the management of extracorporeal membrane oxygenation emergencies a randomized controlled trial zakhary bishoy m kam lily m kaufman brian s more zakhary bishoy m kam lily m kaufman brian s felner kevin j less critical care medicine   august  abstract abstract abstract  favorites pdf request permissions transpulmonary pressure describes lung morphology during decremental positive endexpiratory pressure trials in obesity fumagalli jacopo berra lorenzo zhang changsheng more fumagalli jacopo berra lorenzo zhang changsheng pirrone massimiliano santiago roberta r de santis gomes susimeire magni federico dos santos glaucia a b bennett desmond torsani vinicius fisher daniel morais caio amato marcelo b p kacmarek robert m less critical care medicine   august  abstract abstract abstract  favorites pdf request permissions neurologic critical care hyperchloremia is associated with acute kidney injury in patients with subarachnoid hemorrhage sadan ofer singbartl kai kandiah prem a more sadan ofer singbartl kai kandiah prem a martin kathleen s samuels owen b less critical care medicine   august  abstract abstract abstract  favorites pdf request permissions neurologic injury in adults supported with venovenous extracorporeal membrane oxygenation for respiratory failure findings from the extracorporeal life support organization lorusso roberto gelsomino sandro parise orlando more lorusso roberto gelsomino sandro parise orlando di mauro michele barili fabio geskes gijs vizzardi enrico rycus peter t muellenbach raf mueller thomas pesenti antonio combes alain peek giles frenckner bjorn di nardo matteo swol justyna maessen jos thiagarajan ravi r less critical care medicine   august  abstract abstract abstract  favorites pdf request permissions pediatric critical care abusive head trauma and mortality–an analysis from an international comparative effectiveness study of children with severe traumatic brain injury miller ferguson nikki sarnaik ajit miles darryl more miller ferguson nikki sarnaik ajit miles darryl shafi nadeem peters mark j truemper edward vavilala monica s bell michael j wisniewski stephen r luther james f hartman adam l kochanek patrick m for the investigators of the approaches and decisions in acute pediatric traumatic brain injury adapt trial less critical care medicine   august  abstract abstract abstract  favorites pdf request permissions editorials distinguishing pneumonia from pneumonitis to safely discontinue antibiotics rimawi ramzy husam rimawi ramzy husam less critical care medicine   august   favorites pdf request permissions unplanned picu readmissions a representation of care gaps within the community maraccini amber m slonim anthony d maraccini amber m slonim anthony d less critical care medicine   august   favorites pdf request permissions table of contents sections guest foreword feature articles clinical investigations neurologic critical care pediatric critical care editorials online clinical investigations online laboratory investigations online review article online case reports online letters to the editor    next subscribe to the current table of contents rss feed welcome to ngncapital     ngn biomed opportunity i     ngn biomed opportunity ii       profile     portfolio     contact us       general partners     partners     cfo     venture partners     senior advisors   advisory board       email us     us offices     european office       profile     our team     the location     contact us       civil law     law of succession     family law     intellectual property     commercial law     corporate law     real estate     foreclosure     insolvency     forced sale     labour law     criminal law     international law     community law       relocation       network solutions     ebusiness     internet     web design           general partners venture partners kenneth s abramowitz john r costantino peter johann phd       noah j kroloff alexander cuomo kenneth j gorelick md leon y recanati colin bier phd william j gedale             kenneth s abramowitz kenneth s abramowitz is a cofounder and managing general partner of ngn capital he joined ngn capital from the carlyle group in new york where he was managing director from  to  focused on us buyout opportunities in the healthcare industry beginning july  he transitioned to senior advisor at carlyle in order to devote the time necessary to create a dedicated healthcare fund on behalf of carlyle prior to joining carlyle mr abramowitz worked as an analyst at sanford c bernstein  co where he covered the medicalsupply hospitalmanagement and hmo industries for  years after which he was an egs securities healthcare fund manager he was voted top hospital supply andor service analyst on the institutional investor magazine allamerica research team during  out of  years between  and made “the team” for both healthcare services and medical supplies for  years since  mr abramowitz has published several notable studies on healthcare service companies major medical mergers and cardiovascular device innovation among others he has also published numerous articles in leading journals mr abramowitz earned a ba from columbia university in  and an mba from harvard business school in  mr abramowitz currently sits on the board of directors of benechill inc valtech cardio ltd small bone innovations inc and akorn inc and serves as a board observer at optiscan biomedical corp cerapedics inc and spine view inc he previously served as a director at sightline technologies ltd acquired by stryker power medical interventions acquired by covidien ekos corp  acquired by btg and multiplan acquired by bc partners and silver lake as well as on the boards of medpointe and connecticare holdings inc               john r costantino john r costantino is a managing general partner at ngn capital with  years of private equity experience he was formerly a partner of walden partners a merchantinvestment banking firm and walden capital partners prior to these assignments mr costantino was a partner in costantino melamede  greenberg an investment partnership which specialized in acquiring and managing growth businesses he was also senior executive vice president  coo and a director of conair a leading personal care company with over  billion of revenues he was also president and a managing director of integrated resources acquisition a leveraged buyout firm he started his career at touche ross a major accounting firm where he became the firm’s managing tax partner in new york mr costantino is a trustee of general electric’s family of mutual funds he holds a bs and jd from fordham university and is also a cpa mr costantino is chairman of enzybiotics inc and senior advisor to promosome llc two biotechnology startups formed prior to ngn capital he also serves on the board of directors of act biotech a spinout from bayer pharmaceuticals and vivaldi biosciences and as a board observer at valtech cardio he continues to participate and has served on a number of other domestic and international boards             peter johann phd dr peter johann is a managing general partner of ngn capital he joined from boehringer ingelheim where he was the division head of corporate development dr johann has established a worldwide network in the biotech and pharmaceutical industry his responsibilities at boehringer ingelheim included strategic planning strategic projects ma business development and licensing he identified and evaluated several licensing ma and copromotion deals prior to this dr johann served at f hoffmannla roche as global business leader where he led global business teams and was responsible for global marketing of oncology products as well as evaluation of pipeline products from internal and external sources dr johann joined roche from boehringer mannheim where he was head of business development and marketing molecular medicine besides marketing activities dr johann was involved in setting up and managing joint venture companies as member of the supervisory board he was also responsible for licensing activities in this field prior to that position he had marketing sales and business development responsibilities at boehringer mannheim biochemicals among others for collaborations in the field of biopharmaceuticals dr johann has additional industry experience in business development and marketing of pharmaceutical products with kaneka in japan and with röhm in germany in industrial enzymes dr johann obtained his phd from the technical university munich he currently serves on the board of directors of horizon pharma inc vivaldi biosciences inc resverlogix corporation noxxon pharma ag and exosome diagnostics inc he previously served on the board of directors of jerini ag fwb j acquired by shire pharmaceuticals micromet nasdaq miti which was acquired by amgen and nanirx therapeutics and as an observer on the board of santhera pharmaceuticals ag and cerapedics inc         top of page             noah j kroloff mr kroloff is a partner of ngn capital noah j kroloff has more than  years of experience in healthcare including senior operating roles prior to joining ngn capital mr kroloff was an executive officer of istat corporation nasdaq stat a medical device company where he served as vice president for international sales  marketing and corporate development he was actively involved in the sale of istat to abbott laboratories for approximately  million he also led the creation of a global alliance with abbott and a  million alliance with hewlettpackard medical products group created istat’s international distribution network and led licensing and dealmaking activities prior to istat mr kroloff was an engagement manager at mckinsey  co where he advised leading pharmaceutical and diagnostic companies on rd management portfolio strategy and alliance formation he has also performed significant work for merck and rosetta genomics prior to his work in healthcare he was a senior analyst at fannie mae and an associate at industrial economics inc mr kroloff received his ba in general science from brandeis university and his mba from the mit sloan school   where he cofounded and serves as a judge of the mit k entrepreneurship competition  mr kroloff is a member of the board of directors of valtech cardio ltd and cerapedics inc and is a member of mckinsey’s alumni advisory council and the technion ny metro board       top of page     alexander cuomo alexander cuomo is the chief financial officer of ngn capital mr cuomo joined ngn in  prior to joining ngn he practiced accounting and tax matters primarily for highnet worth individuals family offices partnerships and corporations  mr cuomo’s responsibilities at ngn have included financial reporting tax compliance audit compliance and audit coordination for both the us and german funds other responsibilities include portfolio company valuations internal review and analytics investor relations and general administrative matters  alexander completed his undergraduate degree at ithaca college and his master of science in finance from the lubin school of business at pace university in new york city    top of page       kenneth j gorelick md kenneth j gorelick md has  years of experience in the development of drugs biologics and medical devices in the human health care sector he is currently a consultant to the biopharmaceutical industry dr gorelick has expertise with numerous approvals of blas ndas and maas he has held the position of vice president of global clinical research and development at dupont merck research laboratories inc a researchdriven pharmaceutical company he was also vice president of drug development and chief medical officer at genelabs a biotechnology company focused on infectious and autoimmune disease he currently serves as chief medical officer for pin pharma and chairs the program advisory board for asahi kasei pharma america and is a director of neurotrope bioscience among others  he has a bs from the state university of new york at buffalo a md from weill cornell medical collegeand received postdoctoral training at st louis university and stanford university where he was clinical associate professor of medicine until  dr gorelick is board certified in internal medicine and pulmonary diseases and is a fellow of the american college of chest physicians             leon y recanati leon y recanati is currently the chairman and ceo of glenrock israel ltd a private investment company whose main field of activity is venture capital investments in startup companies engaged in life sciences biotechnology medical devices and in advanced technologies until may  and prior to founding glenrock he served as chairman  ceo of idb holding corporation ltd chairman of clal industries and investments ltd and chairman of azorim investment development and construction ltd in addition to several other positions in a variety of operating companies in israel mr recanati initiated in  clal biotechnologies ltd cbl clal industries invested  million in cbl clal biotechnologies is considered the largest biotechnology investment company operating in israel mr recanati has a mba and bs from the hebrew university of jerusalem and honorary doctorate degrees from the technion  israel institute of technology and tel aviv university mr recanati is actively heading numerous charitable enterprises in israel   top of page       colin b bier phd colin b bier phd is currently the managing director of aba bioresearch inc a bioregulatory consulting firm he is also currently the acting chief scientific officer of enzybiotics inc and a senior advisor to tvm venture capital dr bier has had experience in operating medical scientific and strategic advisory roles at a variety of pharmabiopharma companies at present he is a member of the boards of directors of two public companies bellus health and advitech inc as well as serving on other private company boards he is on the board of directors of mt sinai hospital montreal and holds an appointment at the center for translational research in cancer at the jewish general hospital montreal dr bier earned a phd in experimental pathology at colorado state university and was the former medical research council postdoctoral fellow and the dr douglas james fellow in the department of pathology at mcgill university             william j gedale william j gedale is a senior advisor and cofounder of ngn capital he has been in the investment business since  mr gedale joined ngn from mount everest advisors which he founded in  he has served as an investment advisor to individuals and as a full time consultant to warburgpincus capital management the worlds largest venture capital firm between  and  in this capacity he initiated the  million dollar financing of zymogenetics he also helped arrange the  million funding by sandoz novartis of the scripps research institute and the  million funding of the neuroscience institute of la jolla california of which he is a trustee before founding mount everest advisors he was a managing director at john w bristol  co in  before this as of  mr gedale was president  chief executive officer of general american investors which he had joined in  he is currently chairman of promosone and vice chairman of enzybiotics he has been a director of gamco gabelli holding general american investors allied clinical laboratories us home health care unilab corporation and bioreliance corporation william gedale holds an mba from new york university a jd from fordham law school and an ab from syracuse university he currently serves on the board of directors of pin pharma and previously served on the board of directors of kika medical inc acquired by merge healthcare and bioarray solutions acquired by immucor     top of page print version   home  about ngn   investment professionals    advisors  news  contact us copyright   ngn capital rights reserved         articles by kenneth j gorelick  critical care medicine you may be trying to access this site from a secured browser on the server please enable scripts and reload this page journal logo secondary logo account saved searches recent searches register activate subscription login subscribe help you currently have no recent searches enter your email address wolters kluwer health may email you for journal alerts and information but is committed to maintaining your privacy and will not share your personal information without your express consent for more information please refer to our privacy policy subscribe to etoc   home  current issue  contributor index  gorelick kenneth j articles by kenneth j gorelick a randomized doubleblind placebocontrolled phase b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin art in patients with sepsis vincent jeanlouis ramesh mayakonda k ernest david more vincent jeanlouis ramesh mayakonda k ernest david larosa steven p pachl jan aikawa naoki hoste eric levy howard hirman joe levi marcel daga mradul kutsogiannis demetrios j crowther mark bernard gordon r devriendt jacques puigserver joan vidal blanzaco daniel u esmon charles t parrillo joseph e guzzi louis henderson seton j pothirat chaicharn mehta parthiv fareed jawed talwar deepak tsuruta kazuhisa gorelick kenneth j osawa yutaka kaul inder less critical care medicine   september  abstract abstract abstract  favorites pdf request permissions observations using antiendotoxin antibody e as adjuvant therapy in humans with suspected serious gramnegative sepsis greenberg richard n wilson kathy m kunz arlene y more greenberg richard n wilson kathy m kunz arlene y wedel nancy i gorelick kenneth j less critical care medicine   june  abstract abstract abstract  favorites pdf request permissions human antimepine antibody hama response to mufinf monoclonal antiendotoxin antibodies in the treatment of gpamregative sepsis gns kunz arlene y wodel nancy t saria elizabeth a more kunz arlene y wodel nancy t saria elizabeth a gorelick kenneth j less critical care medicine  s december   favorites pdf request permissions pharmacokinetics and safety of antiendotoxin antibody e e in normal subjects wedel nancy i gorelick kenneth j saria elizabeth a more wedel nancy i gorelick kenneth j saria elizabeth a weidler donald j blaschke terrence f less critical care medicine  s december   favorites pdf request permissions multicenter trial of antiendotoxin antibody e in the treatment of gramnegative sepsis gns gorelick kenneth j schein roland mh macintyre neil r more gorelick kenneth j schein roland mh macintyre neil r emmanuel george bernard gordon r less critical care medicine  s december   favorites pdf request permissions e antiendotoxin antibody in gramnegative sepsis report of a phase ii study gorelick kenneth j wedel nancy i kunz arlene y more gorelick kenneth j wedel nancy i kunz arlene y wilson kathy m greenberg richard n less critical care medicine  s december   favorites pdf request permissions clinical investigation of antilipid a monoclonal antibody xmene in patients with gram negative sepsis gorelick kenneth j harkonen w scott rosendorf linda r more gorelick kenneth j harkonen w scott rosendorf linda r wilson kathy greenberg richard n less critical care medicine   april   favorites pdf request permissions add items to   an existing folder a new folder folder name description the items has been successfully added to  email to a colleague colleagues email is invalid your name optional your email colleagues email separate multiple emails with a  message thought you might appreciate this items i saw at critical care medicine send a copy to your email your message has been successfully sent to your colleague some error has occurred while processing your request please try after some time export to end note procite reference manager save my selection more about this author articles in pubmed by kenneth j gorelick articles in google scholar by kenneth j gorelick kenneth j gorelick  pseps venture data skip to main content fundsventurefunds of fundsreal estatemezzaninebuyoutinfrastructuresecondariesperformance rankingsindustriesmanufacturingcomputer electronic and optical productsbatteriesmedical devicesmedical suppliespharmaceuticalsinformation servicesinvestorsseedseries aother ventureacquisitionsindividualsgrants kenneth j gorelick dr kenneth j gorelick md overviewkenneth gorelick md has  years of experience in the development of drugs and biologics in the human health care sector he is currently president and chief operating officer of enzybiotics llc a privately held biotechnology company and a consultant to the pharmaceutical industry dr gorelick has expertise with numerous approvals of blas ndas and maas prior to these assignments dr gorelick held the position of vice president of global clinical research and development at dupont merck research laboratories inc a researchdriven pharmaceutical company he was also vice president of drug development at genelabs a biotechnology company focused on infectious and autoimmune disease dr gorelick was clinical associate professor of medicine at stanford university until  he holds a bs from the state university of new york at buffalo and a md from weill medical college of cornell university he is board certified in internal medicine and pulmonary diseases he is a fellow of the american college of chest physicians career ngn capital      fund management position venture partner new york current edit delete add a position add a job education cornell university     degree na  array  edit delete add degree add education pseps id  search form search more like this randall whitcomb marlene r krauss thomas r beck shelley chu mason freeman kapila ratnam marc e lippman investment themes funds d printing advanced materials artificial intelligence augmented and virtual reality ar vr automotive blockchain cybersecurity drones  uavs education electric vehicles energy harvesting energy storage fintech internet of things iot nanotechnology robotics sensors wearable technology user login username  password  create new account request new password navigation stock exchanges terms of use  copyright  by pseps ltd all rights reserved neurotrope announces josh silverman and dr ken gorelick to the board of directors email protected twitterlinkedin about our vision our mission our team our values our partners faq terms  conditions privacy policy board news latest board news board news by location… europe usa  canada middle east all the others board news by company type public  listed vc  pe backed privately held trust  fund  reit board news by industry… life sciences  health care financials information technology women on board submit a press release board directory company press releases public  listed global  fortune  private or vc  pe backed unicorns trust  fund newsletter contact log in register select pageabout    our vision our mission     our team     our values     our partners     faq     terms  conditions     privacy policy board news    latest board news     board news by location…        europe         usa  canada         middle east         all the others     board news by company type        public  listed         vc  pe backed         privately held         trust  fund  reit     board news by industry…        life sciences  health care         financials         information technology     women on board     submit a press release board directory    company press releases     public  listed     global      fortune      private or vc  pe backed     unicorns     trust  fund newsletter contact log in register homeboard  usa  can board listedpublic companies neurotrope announces josh silverman and dr ken gorelick to the board of directors neurotrope announces josh silverman and dr ken gorelick to the board of directors august   by talentboards team comments are off board  usa  can board listedpublic companies – usa nj – neurotrope inc otcbb ntrp focused on developing drugs to treat neurological diseases including alzheimer’s disease today announced it has reached a settlement agreement with iroquois master fund ltd and certain of its affiliates with regard to a proposed consent solicitation by iroquois as part of the settlement paul e freiman and jay m haft resigned from the board of directors of the company effective immediately the board appointed mr joshua silverman chairman of the board and dr kenneth j gorelick to the board effective immediately “we are pleased to have worked constructively with neurotrope and commend neurotrope’s board for its thoughtful engagement over the past few weeks” stated josh silverman cofounder of iroquois capital management llc and new member of the board “we believe that this newly composed board with the addition of dr gorelick will help maximize the company’s potential and enhance stockholder value” “i believe that neurotrope is positioned to play an important role in restorative brain therapeutics through its pioneering development of drugs that induce the growth of new synapses and that prevent the death of neurons its novel technology potentially addresses critical unmet medical needs in the treatment of alzheimer’s disease fragile x syndrome and other serious neurologic disorders” dr gorelick added “its strong science and unique approach are what attracted me to neurotrope and i look forward to contributing to the company’s growth and future value creation as a director” in addition the company’s chief executive officer and president charles ramat entered into a separation agreement with the company pursuant to which he shall remain on as a consultant and resign from the board and all other positions that he holds with the company including chief executive officer and president on october   the company will commence a search for a new chief executive officer with significant experience in the biotechnology industry dr gorelick is the managing director of zymo consulting group llc that provides consulting services to the biopharmaceutical industry specializing in clinical development and regulatory affairs he currently serves as chair of the program advisory board for asahi kasei pharma america and as chief medical officer for pin pharma among others dr gorelick received his md from cornell university and postdoctoral training at st louis university and stanford university where he was also a member of the clinical faculty previously he was vice president of global clinical research and development at dupont merck pharmaceutical company about neurotrope neurotrope bioscience inc a wholly owned subsidiary of neurotrope inc is at the forefront of biotechnology companies having a focus on developing a novel therapy for the treatment of moderately severe to severe alzheimer’s disease the scientific basis of our treatment is activation of protein kinase c isozymes ε and α by bryostatin a natural product which in mouse ad models was demonstrated to result in repair of damaged synapses as well as synaptogenesis reduction of toxic betaamyloid generation and enhancement of memory and learning thus having the potential to improve cognition and behavior in alzheimer’s disease neurotrope is also conducting preclinical studies of bryostatin as a treatment for fragile x syndrome and niemannpick type c disease two rare genetic diseases for which only symptomatic treatments are currently available the fda has granted orphan drug designation to neurotrope for bryostatin as a treatment for fragile x syndrome bryostatin has undergone testing in over  people establishing a large safety database neurotrope has exclusively licensed technology from the blanchette rockefeller neurosciences institute for alzheimer’s disease and fragile x syndrome has a worldwide exclusive license with the icahn school of medicine at mt sinai for niemannpick type c disease and is partnered with stanford university to synthesize and find the next generation bryostatin – called bryologs  disclaimer  news data and statement included in this release are intended exclusively for information purposes product and brand names used in this release maybe trademarks or registered trade marks of their respective owners talentboards accepts neither liability for the consequences of the reader’s reliance nor responsibility for the adequacy or accuracy of this release no data or statement in this release should be considered a recommendation for the purchase retention or sale of the securities referred to hereinother related postsneurotrope appoints dr susanne wilke to its board of directorsanavex life sciences appoints dr peter donhauser to its board of directorsalzheon appoints jeanpierre sommadossi to its board of directorstalentboards teamhere the original post  comments are closed latest boardroom news standard chartered announces dr ngozi okonjoiweala to its board as upcoming independent nonexecutive director july   tristar resources appoints mark wellesleywood as executive chairman july   pacific city financial appoints sang lee as new chairman of the board of directors july   medallion financial adds john everets to its board as independent director july   morgan stanley announces board member tom glocer as upcoming independent lead director july   random boardsenergiser investmentscts corporationtymanwexsevenhugs    talentboards inc  all rights reserved  geneva  miami  london  boston  paris  shanghai  monaco  august   volume   issue   contributor index  critical care medicine you may be trying to access this site from a secured browser on the server please enable scripts and reload this page journal logo secondary logo account saved searches recent searches register activate subscription login subscribe help you currently have no recent searches enter your email address wolters kluwer health may email you for journal alerts and information but is committed to maintaining your privacy and will not share your personal information without your express consent for more information please refer to our privacy policy subscribe to etoc   home  current issue  contributor index add items to   an existing folder a new folder folder name description the items has been successfully added to  email to a colleague colleagues email is invalid your name optional your email colleagues email separate multiple emails with a  message thought you might appreciate this items i saw at critical care medicine send a copy to your email your message has been successfully sent to your colleague some error has occurred while processing your request please try after some time export to end note procite reference manager save my selection august   volume   issue   contributor index alphabetical search view all a b c d e f g h i j k l m n o p q r s t u v w x y z author aicuarapun irene md lower cranial nerves paralysis following proneposition mechanical ventilation trejogabrielgalan jose m perearodriguez maria eugenia aicuarapun irene more trejogabrielgalan jose m perearodriguez maria eugenia aicuarapun irene martinezbarrio esther less critical care medicine  ee august  abstract abstract abstract  favorites pdf request permissions author alsubaie nawaf md dysglycemia glycemic variability and outcome after cardiac arrest and temperature management at °c and °c borgquist ola wise matt p nielsen niklas more borgquist ola wise matt p nielsen niklas alsubaie nawaf cranshaw julius cronberg tobias glover guy hassager christian kjaergaard jesper kuiper michael smid ondrej walden andrew friberg hans for the ttmtrial investigators less critical care medicine   august  abstract abstract abstract  favorites pdf request permissions author alegría leyla rn mph organizational issues structure and processes of care in  icus in latin america a study from the latin america intensive care network estenssoro elisa alegría leyla murias gastón more estenssoro elisa alegría leyla murias gastón friedman gilberto castro ricardo nin vaeza nicolas loudet cecilia bruhn alejandro jibaja manuel ospinatascon gustavo ríos fernando machado flavia r biasi cavalcanti alexandre dubin arnaldo hurtado f javier briva arturo romero carlos bugedo guillermo bakker jan cecconi maurizio azevedo luciano hernandez glenn on behalf of the latinamerican intensive care network liven less critical care medicine   august  abstract abstract abstract  favorites pdf request permissions author amato marcelo b p md phd transpulmonary pressure describes lung morphology during decremental positive endexpiratory pressure trials in obesity fumagalli jacopo berra lorenzo zhang changsheng more fumagalli jacopo berra lorenzo zhang changsheng pirrone massimiliano santiago roberta r de santis gomes susimeire magni federico dos santos glaucia a b bennett desmond torsani vinicius fisher daniel morais caio amato marcelo b p kacmarek robert m less critical care medicine   august  abstract abstract abstract  favorites pdf request permissions author andrews meghan frcpc challenging authority during an emergency—the effect of a teaching intervention friedman zeev perelman vsovolod mcluckie duncan more friedman zeev perelman vsovolod mcluckie duncan andrews meghan noble laura m k malavade archana bould m dylan less critical care medicine  ee august  abstract abstract abstract  favorites pdf request permissions author anesi george l md mbe validation of an administrative definition of icu admission using revenue center codes weissman gary e hubbard rebecca a kohn rachel more weissman gary e hubbard rebecca a kohn rachel anesi george l manaker scott kerlin meeta prasad halpern scott d less critical care medicine  ee august  abstract abstract abstract  favorites pdf request permissions author apers thomas md atriobronchial fistula complicated by septic cerebral air emboli after pulmonary vein ablation velghe david apers thomas devriendt stefanie more velghe david apers thomas devriendt stefanie deblier ivo hendriks bart nieuwendijk rogier rogiers peter less critical care medicine  ee august  abstract abstract abstract  favorites pdf request permissions author arulkumaran nishkantha phd mrcp sequential analysis of a panel of biomarkers and pathologic findings in a resuscitated rat model of sepsis and recovery arulkumaran nishkantha sixma marije l jentho elisa more arulkumaran nishkantha sixma marije l jentho elisa ceravola elias bass paul s kellum john a unwin robert j tam fred w k singer mervyn less critical care medicine  ee august  abstract abstract abstract go to full text of this article  favorites pdf request permissions author atherly adam j phd recommendations for methicillinresistant staphylococcus aureus prevention in adult icus a costeffectiveness analysis whittington melanie d atherly adam j curtis donna j more whittington melanie d atherly adam j curtis donna j lindrooth richard c bradley cathy j campbell jonathan d less critical care medicine   august  abstract abstract abstract  favorites pdf request permissions author aubry florent phd brain gray matter mri morphometry for neuroprognostication after cardiac arrest silva stein peran patrice kerhuel lionel more silva stein peran patrice kerhuel lionel malagurski briguita chauveau nicolas bataille benoit lotterie jean albert celsis pierre aubry florent citerio giuseppe jean betty chabanne russel perlbarg vincent velly lionel galanaud damien vanhaudenhuyse audrey fourcade olivier laureys steven puybasset louis less critical care medicine  ee august  abstract abstract abstract go to full text of this article  favorites pdf request permissions author azevedo luciano md organizational issues structure and processes of care in  icus in latin america a study from the latin america intensive care network estenssoro elisa alegría leyla murias gastón more estenssoro elisa alegría leyla murias gastón friedman gilberto castro ricardo nin vaeza nicolas loudet cecilia bruhn alejandro jibaja manuel ospinatascon gustavo ríos fernando machado flavia r biasi cavalcanti alexandre dubin arnaldo hurtado f javier briva arturo romero carlos bugedo guillermo bakker jan cecconi maurizio azevedo luciano hernandez glenn on behalf of the latinamerican intensive care network liven less critical care medicine   august  abstract abstract abstract  favorites pdf request permissions author bachoumas konstantinos md antibiotic therapy in comatose mechanically ventilated patients following aspiration differentiating pneumonia from pneumonitis lascarrou jean baptiste lissonde floriane le thuaut aurélie more lascarrou jean baptiste lissonde floriane le thuaut aurélie bachoumas konstantinos colin gwenhael henry lagarrigue matthieu vinatier isabelle fiancette maud lacherade jean claude yehia aihem joret aurélie lebert christine bourdon sandra martin lefèvre laurent reignier jean less critical care medicine   august  abstract abstract abstract go to full text of this article  favorites pdf request permissions author badawi omar pharmd mph fccm the authors reply harris kimberley zhou jiachen liu xinggang more harris kimberley zhou jiachen liu xinggang hassan erkan badawi omar less critical care medicine  ee august   favorites pdf request permissions author baggs judith gedney phd rn faan improving medical icu outcomes promoting respect and ongoing safety through patient engagement communication and technology study baggs judith gedney baggs judith gedney less critical care medicine   august   favorites pdf request permissions author bakker jan md organizational issues structure and processes of care in  icus in latin america a study from the latin america intensive care network estenssoro elisa alegría leyla murias gastón more estenssoro elisa alegría leyla murias gastón friedman gilberto castro ricardo nin vaeza nicolas loudet cecilia bruhn alejandro jibaja manuel ospinatascon gustavo ríos fernando machado flavia r biasi cavalcanti alexandre dubin arnaldo hurtado f javier briva arturo romero carlos bugedo guillermo bakker jan cecconi maurizio azevedo luciano hernandez glenn on behalf of the latinamerican intensive care network liven less critical care medicine   august  abstract abstract abstract  favorites pdf request permissions author balakumar vikram md both positive and negative fluid balance may be associated with reduced longterm survival in the critically ill balakumar vikram murugan raghavan sileanu florentina e more balakumar vikram murugan raghavan sileanu florentina e palevsky paul clermont gilles kellum john a less critical care medicine  ee august  abstract abstract abstract  favorites pdf request permissions author barili fabio md phd neurologic injury in adults supported with venovenous extracorporeal membrane oxygenation for respiratory failure findings from the extracorporeal life support organization lorusso roberto gelsomino sandro parise orlando more lorusso roberto gelsomino sandro parise orlando di mauro michele barili fabio geskes gijs vizzardi enrico rycus peter t muellenbach raf mueller thomas pesenti antonio combes alain peek giles frenckner bjorn di nardo matteo swol justyna maessen jos thiagarajan ravi r less critical care medicine   august  abstract abstract abstract  favorites pdf request permissions author bass paul s mrcpath sequential analysis of a panel of biomarkers and pathologic findings in a resuscitated rat model of sepsis and recovery arulkumaran nishkantha sixma marije l jentho elisa more arulkumaran nishkantha sixma marije l jentho elisa ceravola elias bass paul s kellum john a unwin robert j tam fred w k singer mervyn less critical care medicine  ee august  abstract abstract abstract go to full text of this article  favorites pdf request permissions author bataille benoit md brain gray matter mri morphometry for neuroprognostication after cardiac arrest silva stein peran patrice kerhuel lionel more silva stein peran patrice kerhuel lionel malagurski briguita chauveau nicolas bataille benoit lotterie jean albert celsis pierre aubry florent citerio giuseppe jean betty chabanne russel perlbarg vincent velly lionel galanaud damien vanhaudenhuyse audrey fourcade olivier laureys steven puybasset louis less critical care medicine  ee august  abstract abstract abstract go to full text of this article  favorites pdf request permissions author bates david w md msc prospective evaluation of a multifaceted intervention to improve outcomes in intensive care the promoting respect and ongoing safety through patient engagement communication and  dykes patricia c rozenblum ronen dalal anuj more dykes patricia c rozenblum ronen dalal anuj massaro anthony chang frank clements marsha collins sarah donze jacques fagan maureen gazarian priscilla hanna john lehmann lisa leone kathleen lipsitz stuart mcnally kelly morrison conny samal lipika mlaver eli schnock kumiko stade diana williams deborah yoon catherine bates david w less critical care medicine  ee august  abstract abstract abstract  favorites pdf request permissions      next caprally find investors features pricing about login sign up results filter all sectors energy healthcare technology other all stages seed early growth argentina australia brazil canada china france germany hong kong india ireland israel japan jersey korea luxembourg russia singapore sweden switzerland the netherlands united kingdom united states go kenneth j gorelick venture partner  ngn capital new york ny     companies affiliations  about kenneth j gorelick kenneth gorelick md has  years of experience in the development of drugs and biologics in the human health care sector he is currently president and chief operating officer of enzybiotics llc a privately held biotechnology company and a consultant to the pharmaceutical industry dr gorelick has expertise with numerous approvals of blas ndas and maas prior to these assignments dr gorelick held the position of vice president of global clinical research and development at dupont merck research laboratories inc a researchdriven pharmaceutical company he was also vice president of drug development at genelabs a biotechnology company focused on infectious and autoimmune disease dr gorelick was clinical associate professor of medicine at stanford university until  he holds a bs from the state university of new york at buffalo and a md from weill medical college of cornell university he is board certified in internal medicine and pulmonary diseases he is a fellow of the american college of chest physiciansn related professionals  kenna baudin director reginald chambers principal richard ulevitch venture partner paul a stone general counsel and chief operating officer susan adams cfo c sage givens managing director david s heer managing director jakki haussler partner deidre cunnane general counsel thomas a boman senior vice president of tax charles h booker senior vice president ryan m brennan managing director jeffrey w craver principal maurice e doyle managing director deborah f dubin strategic communications louis t dubuque managing director michael t johnson managing director thomas w keaveney board member  senior advisor franchesca b lorio vice presidentcontroller stuart s noel senior associate damon l rawie managing director adam m suberi vice president raymond m wagner associate thomas c willsey senior vice president treasury scott a zajac senior managing director charles jablonski venture advisor tony di bona cfo general partner david pezeshki controller nancy lee chief financial officer eileen mccarthy toti general partner  chief financial officer jessica barry reed vice president chris dias associate ron ondechek associate marc gulley controller alan beringsmith chief financial officer j david jacobs general counsel caroline l marple director of operations cynthia m rossetti director of finance loretta m mcclary tax counsel randall e poliner founder jonathan i kislak   jonathan e cole advisor tom domencich advisor stephen snyder advisor c meade sutterfield advisor xander perry partner ed spiva partner marcy marshall chief financial officer linnea j geiss principal steven lazarus cofounder  managing director emeritus edgar hotard venture partner hong hou venture partner george kadifa venture partner tom brennan venture partner nicholas darby executive in residence david cruikshank associate donald hall managing director edwin a moss venture partner philip b smith advisor victor kats investment manager todd miltenberger senior investment analyst thomas j scanlon vice president of finance michio fujimura managing director nancy mccroskey chief financial officer katherine blum general counsel steven simonian chief financial officer jeff garvey founder jeff browning recruiting partner john dirvin partner  chief operating officer kevin kunz chief financial officer dave benton vice president of technology mike millard director of research peter a hunter managing director james a pelusi managing director lawrence b evans advisor john h ricketson advisor peter russo advisor john kneen partner brenton m clark associate david m ruby associate leslie a shipley director of operations andi jenkins director of marketing and communications robert p driscoll director of finance jeff d edelson extramural entrepreneur  scientific liaison marnie mccoy program director jennifer d smith director of administration amy rosen wildstein fund manager chris randles entrepreneurinresidence emeritus mark sawyer entrepreneurinresidence emeritus william m degroot associate bruce r tiedemann partner  chief financial officer vinit nijhawan managing director eric a schultz chief financial officer joao paulo poiares baptista managing director marietta wu director simon waddington entrepreneurinresidence daniel alexander cofounder eugene e pettinelli cofounder tricia moriarty vice president of finance and administration karen kassouf managing member ken fox director julianne kampling advisor andrea serrate consultant donald w moran advisor cynthia kassouf advisor david gaither advisor thao h duong investment administrator devdutt yellurkar investment professional hassan ahmed advisor dave latzke investment professional wade myers investment professional keith tufte investment professional jane bortnem vice president of finance liz oniell senior accountant chari fournier marketing associate elizabeth rounsavall director of research and analytics lisa aly vice president of finance and administration tom weithman managing director jennifer odaniel senior associate don doering partner paul yau partner martha p e arscott cfo stepheni j harpin investment analyst julie f rader director wayne jackson advisor ken krieg advisor phillip merrick advisor david steinberg advisor carl simpson managing director wil samson managing partner mark klopp managing director clint korver venture partner brian adamsky chief administrative officer  managing director richard fox managing director frederick tecce managing director carter caldwell principal rahul singh principal james b daugherty venture partner tom bliska general partner isabelle fymat general partner stephen perkins general partner paul sabo head of trading jon schwartz vice president matthew mcelhattan principal richard pardoe principal colleen mazza business support c raymond larkin venture partner stephen b solomon md venture partner john j cadeddu managing director young j chung managing director john m duff jr managing director r thomas goodrich managing director nicholas k pianim managing director kendra h ragatz venture partner osuke honda partner gen isayama partner doris pan analyst edward tsai investment vp ramon zeng investment vp tony zhang investment vp matthew bonner legal and operations partner rudolph rehm finance partner cathy minshall chief financial officer stan sakai partner masa isono principal kyoko watanabe director of finance and operations matthew t potter chief financial officer eugene galantini chief financial officer mark greenstein managing director don plaisted senior associate cynthia lam chief financial officer michelle waldusky director michael blaustein managing director howard lau managing director salvatore massaro general partner charles silio senior associate keith burge general partner nancy haar general partner sean drake partner thomas buffa general counsel ken yasunaga managing partner yoshito yamamoto administrative partner salem d shuchman managing partner bruce j newman partner john garel senior managing director kevin wilson senior managing director ryan davis chief financial officer robert pothier venture partner graham ds anderson general partner milton j pappas general partner stephen k reidy general partner raymond j whitaker phd general partner frank t lin principal joanne brown ccm vice president of finance administration henry h corning chairman of the board john a tony mayer jr board member frohman anderson board member cheryl goyette partner and cfo melissa packard director of finance jim case vice president finance eric golding associate jeff donnon chief financial officer geofreyf von maltzahn new venture principal dick farrahar senior vp of executive operations greg sieczkiewicz vp of intellectual property amey moot director frank legacki director molly hoult director janice disanto director of finance and administration paula l marez director of finance  operations kristen bailey director of finance joseph r rondinelli associate philip coats controller n rudy garza founder  managing general partner david lunsford advisor wan li zhu partner eric olson associate judy dorr cfo kush m parmar senior associate alan ying venture partner derek fricke associate jamie bellanca operating partner jarett carson managing director hoon chung entrepreneur in residence eric grad analyst rachid sefrioui managing director david espitallier principal kitty walker office coordinator debbie fritzer accounting manager investment analyst greg e paulson venture partner jeanne henry cfo richard t hummell ii principal rob d ospalik director of portfolio management beverly brown director of development dirk lammerts managing director evan macqueen associate boyu hu associate jason krikorian general partner benjamin tseng associate xander mahony investment professional rachel liu analyst yrsa nordlicht controller matt reisman venture fellow john l cecil advisor david jargiello general counsel  venture partner lisa parks vice president of analysis chiamin lai senior associate frank mcevoy investment professional john mumford founding partner dede barsotti chief administrative partner don milder general partner emeritus rich shapero managing partner seth neiman managing partner bob hoff general partner jim dorrian general partner anthony metzner vice president timothy w hassler principal merrill f hoopengardner senior vice president joe alsop venture partne patty wong office manager itzhak reichman venture partner dan kidle analyst michael gilb associate andrew thornborrow operating partner – legal and finance wei cao director frank wu analyst charles rim venture partner songbo li venture partner michael cheng senior associate brandon farwell investment professional ankur gulati investment professional whitney warnock office manager gaye bok venture partner jim dougherty venture partner jeff folick senior advisor tom hodge coo  general partner steve bailey cfo bridget rauvola investor relations  marketing partner jennifer p henderson associate robert a schuster associate janet kerman accounting geoff mamlet principal mel davidson cfo eryn lampe operations manager megan campbellrisen office manager leslie elgood president  ceo michael emerson vicepresident strategic business services leonard hirsch chief financial officer leon y recanati venture partner colin b bier senior advisor newton howard investment professional richard wirt investment professional ammar qusaibaty investment professional sergey kanareykin investment professional robert n savoie partner and coo arun ramamoorthy principal donal d delaney chief financial officer sharon lau analyst dave mixer cofounding partner samir housri associate farooq javed associate dan slifko president  director bob savage fund manager jon klotz entrepreneur in residence carol marino vicepresident ignacio martinez principal derek norman investment manager josh elman principal charles hudson venture partner john g freund managing director eric gordon partner david g lowe managing director glenn reicin venture partner bill fitzgerald managing director and chief financial officer nitesh banta associate michelle daubar vp communications peter freeland growth equity vice president hugh crean entrepreneur in residence deepak jeevan kumar senior associate terry jones special venture partner frank maher controller brian shortsleeve managing director matt tara growth equity  vice president paul verrochi entrepreneur in residence dave markland cfo  administrative partner arjun bhimavarapu analyst josh bruno associate shannon harrington startup academy program leader mike lewis analyst greg mervine associate aditya panda analyst erin wise business manager sylvia kuyel senior associate robert e kelly chief financial officer richard l veron of counsel joan m jennings office manager o gene gabbard venture partner dev saxena analyst bill lyons venture partner greg gunn entrepreneur in residence james keyes advisor david tyson advisor mary k bush advisor stewart satter advisor maryam paracha executive assistant kun ma director of venture analysis dawn cherry executive assistant dan sheehan managing director dave neustaedter vice president amy belt director joe graham associate karey barker managing director samuel stewart investment committee member john malooly investment committee member peter jarman director tyler christenson director sherry ward executive assistant lisa hagerman director of dbl programs patrick sagisi associate sarah ham associate carol wong fund manage thomas fogarty managing director bob brownell managing director kate castle vice president of marketing matt guiney controller bruce revzin chief financial officer jeffrey s muir partner alston gardner venture partner philip lewis director edward robson analyst lee tidwell investor relations  office manager jon j lauckner president sherwin l prior managing director tim brumbaugh deputy director john hater investment manager anish patel investment manager jerneja loncar investment manager brian cayce principal nikhil dandavati investment analyst mark hand investment analyst john hardman investment manager margaret yuan investment analyst meghan pfeifer senior finance associate sharon gogol controller berge ayvazian advisor dawn hudson advisor betsy bernard advisor preston padden advisor james bailey analyst eric j rothfus managing partner joseph thompson partner darren c wallis partner michael d falcon partner david l jannetta associate andy maunder venture partner charles haythornthwaite vice president investments james chepyha vice president of investments alberta osman malik associate wendy leong director of finance christen myles administrative assistant rick sirvaitis president storeboards media operating partner brian kempner chief operating officer and general counsel nick marsh venture partner andy macdonald venture partner danielle hootnick vice president marketing  investor relations daniel gaisin controller paul cianciolo senior associate diego a gutierrez it systems kirill sheynkman venture partner alan gould executive in residence david rodriguez associate joanne bradford advisor rishad tobaccowala advisor rob norman advisor bill doyle managing director tim langloss managing director raymond wu associate stephen liou associate beth bencel chief administrative officer jacob van naarden associate connie chen analyst lloyd e appel chief financial officer robert j wenzel controller jan hoerrner director of investor relations and marketing timothy n teen founding managing partner chris brady jr associate evan klebe senior associate donald mcdonough principal gabe nadel associate jim rutherfurd partner vaibhav vish associate jenny m lee vice president finance jennifer e parulo cfo venture capital matthew j kline senior financial analyst andrea s adams treasurer ryan c dressler analyst daniel j drury tax manager jonathan i goldstein managing director philip e marshall principal kari e niermann senior associate pam hall controller brian duncan venture partner zaz floreani director of business development matt kronmiller analyst rob bearden venture partner shane elliot partner kate justham business development executive stephane mery partner malcolm moss founding partner nishal shah financial controller marette thair office coordinator steven tuckley chief financial officer scott kabbes operating partner morgan mosky associate matthew pettit senior associate dag dvergsten venture partner scandinavia ryan kelly associate alex euler director sean mallon senior director of investments derrick smith senior associate jim larrick venture partner life sciences edward schnipper chief medical officer life sciences erik sebusch partner evan decorte senior associate andrew hedin analyst marieclaude boisvert chief operating officer roger durand vicepresident development capital ed rendell operating partner david wolfe founding member paul hirschbiel founding member ryan hemingway associate a bliss mccrum partner emeritus michael fritz associate avak kahvejian vice president development  partner venturelabs chuck carelli controller gene trainor chief operating officer william t wright associate show more features pricing about terms privacy help feedback contact us   caprally inc all rights reserved welcome to ngncapital     ngn biomed opportunity i     ngn biomed opportunity ii       profile     portfolio     contact us       general partners     partners     cfo     venture partners     senior advisors   advisory board       email us     us offices     european office       profile     our team     the location     contact us       civil law     law of succession     family law     intellectual property     commercial law     corporate law     real estate     foreclosure     insolvency     forced sale     labour law     criminal law     international law     community law       relocation       network solutions     ebusiness     internet     web design           general partners venture partners kenneth s abramowitz john r costantino peter johann phd       noah j kroloff alexander cuomo kenneth j gorelick md leon y recanati colin bier phd william j gedale             kenneth s abramowitz kenneth s abramowitz is a cofounder and managing general partner of ngn capital he joined ngn capital from the carlyle group in new york where he was managing director from  to  focused on us buyout opportunities in the healthcare industry beginning july  he transitioned to senior advisor at carlyle in order to devote the time necessary to create a dedicated healthcare fund on behalf of carlyle prior to joining carlyle mr abramowitz worked as an analyst at sanford c bernstein  co where he covered the medicalsupply hospitalmanagement and hmo industries for  years after which he was an egs securities healthcare fund manager he was voted top hospital supply andor service analyst on the institutional investor magazine allamerica research team during  out of  years between  and made “the team” for both healthcare services and medical supplies for  years since  mr abramowitz has published several notable studies on healthcare service companies major medical mergers and cardiovascular device innovation among others he has also published numerous articles in leading journals mr abramowitz earned a ba from columbia university in  and an mba from harvard business school in  mr abramowitz currently sits on the board of directors of benechill inc valtech cardio ltd small bone innovations inc and akorn inc and serves as a board observer at optiscan biomedical corp cerapedics inc and spine view inc he previously served as a director at sightline technologies ltd acquired by stryker power medical interventions acquired by covidien ekos corp  acquired by btg and multiplan acquired by bc partners and silver lake as well as on the boards of medpointe and connecticare holdings inc               john r costantino john r costantino is a managing general partner at ngn capital with  years of private equity experience he was formerly a partner of walden partners a merchantinvestment banking firm and walden capital partners prior to these assignments mr costantino was a partner in costantino melamede  greenberg an investment partnership which specialized in acquiring and managing growth businesses he was also senior executive vice president  coo and a director of conair a leading personal care company with over  billion of revenues he was also president and a managing director of integrated resources acquisition a leveraged buyout firm he started his career at touche ross a major accounting firm where he became the firm’s managing tax partner in new york mr costantino is a trustee of general electric’s family of mutual funds he holds a bs and jd from fordham university and is also a cpa mr costantino is chairman of enzybiotics inc and senior advisor to promosome llc two biotechnology startups formed prior to ngn capital he also serves on the board of directors of act biotech a spinout from bayer pharmaceuticals and vivaldi biosciences and as a board observer at valtech cardio he continues to participate and has served on a number of other domestic and international boards             peter johann phd dr peter johann is a managing general partner of ngn capital he joined from boehringer ingelheim where he was the division head of corporate development dr johann has established a worldwide network in the biotech and pharmaceutical industry his responsibilities at boehringer ingelheim included strategic planning strategic projects ma business development and licensing he identified and evaluated several licensing ma and copromotion deals prior to this dr johann served at f hoffmannla roche as global business leader where he led global business teams and was responsible for global marketing of oncology products as well as evaluation of pipeline products from internal and external sources dr johann joined roche from boehringer mannheim where he was head of business development and marketing molecular medicine besides marketing activities dr johann was involved in setting up and managing joint venture companies as member of the supervisory board he was also responsible for licensing activities in this field prior to that position he had marketing sales and business development responsibilities at boehringer mannheim biochemicals among others for collaborations in the field of biopharmaceuticals dr johann has additional industry experience in business development and marketing of pharmaceutical products with kaneka in japan and with röhm in germany in industrial enzymes dr johann obtained his phd from the technical university munich he currently serves on the board of directors of horizon pharma inc vivaldi biosciences inc resverlogix corporation noxxon pharma ag and exosome diagnostics inc he previously served on the board of directors of jerini ag fwb j acquired by shire pharmaceuticals micromet nasdaq miti which was acquired by amgen and nanirx therapeutics and as an observer on the board of santhera pharmaceuticals ag and cerapedics inc         top of page             noah j kroloff mr kroloff is a partner of ngn capital noah j kroloff has more than  years of experience in healthcare including senior operating roles prior to joining ngn capital mr kroloff was an executive officer of istat corporation nasdaq stat a medical device company where he served as vice president for international sales  marketing and corporate development he was actively involved in the sale of istat to abbott laboratories for approximately  million he also led the creation of a global alliance with abbott and a  million alliance with hewlettpackard medical products group created istat’s international distribution network and led licensing and dealmaking activities prior to istat mr kroloff was an engagement manager at mckinsey  co where he advised leading pharmaceutical and diagnostic companies on rd management portfolio strategy and alliance formation he has also performed significant work for merck and rosetta genomics prior to his work in healthcare he was a senior analyst at fannie mae and an associate at industrial economics inc mr kroloff received his ba in general science from brandeis university and his mba from the mit sloan school   where he cofounded and serves as a judge of the mit k entrepreneurship competition  mr kroloff is a member of the board of directors of valtech cardio ltd and cerapedics inc and is a member of mckinsey’s alumni advisory council and the technion ny metro board       top of page     alexander cuomo alexander cuomo is the chief financial officer of ngn capital mr cuomo joined ngn in  prior to joining ngn he practiced accounting and tax matters primarily for highnet worth individuals family offices partnerships and corporations  mr cuomo’s responsibilities at ngn have included financial reporting tax compliance audit compliance and audit coordination for both the us and german funds other responsibilities include portfolio company valuations internal review and analytics investor relations and general administrative matters  alexander completed his undergraduate degree at ithaca college and his master of science in finance from the lubin school of business at pace university in new york city    top of page       kenneth j gorelick md kenneth j gorelick md has  years of experience in the development of drugs biologics and medical devices in the human health care sector he is currently a consultant to the biopharmaceutical industry dr gorelick has expertise with numerous approvals of blas ndas and maas he has held the position of vice president of global clinical research and development at dupont merck research laboratories inc a researchdriven pharmaceutical company he was also vice president of drug development and chief medical officer at genelabs a biotechnology company focused on infectious and autoimmune disease he currently serves as chief medical officer for pin pharma and chairs the program advisory board for asahi kasei pharma america and is a director of neurotrope bioscience among others  he has a bs from the state university of new york at buffalo a md from weill cornell medical collegeand received postdoctoral training at st louis university and stanford university where he was clinical associate professor of medicine until  dr gorelick is board certified in internal medicine and pulmonary diseases and is a fellow of the american college of chest physicians             leon y recanati leon y recanati is currently the chairman and ceo of glenrock israel ltd a private investment company whose main field of activity is venture capital investments in startup companies engaged in life sciences biotechnology medical devices and in advanced technologies until may  and prior to founding glenrock he served as chairman  ceo of idb holding corporation ltd chairman of clal industries and investments ltd and chairman of azorim investment development and construction ltd in addition to several other positions in a variety of operating companies in israel mr recanati initiated in  clal biotechnologies ltd cbl clal industries invested  million in cbl clal biotechnologies is considered the largest biotechnology investment company operating in israel mr recanati has a mba and bs from the hebrew university of jerusalem and honorary doctorate degrees from the technion  israel institute of technology and tel aviv university mr recanati is actively heading numerous charitable enterprises in israel   top of page       colin b bier phd colin b bier phd is currently the managing director of aba bioresearch inc a bioregulatory consulting firm he is also currently the acting chief scientific officer of enzybiotics inc and a senior advisor to tvm venture capital dr bier has had experience in operating medical scientific and strategic advisory roles at a variety of pharmabiopharma companies at present he is a member of the boards of directors of two public companies bellus health and advitech inc as well as serving on other private company boards he is on the board of directors of mt sinai hospital montreal and holds an appointment at the center for translational research in cancer at the jewish general hospital montreal dr bier earned a phd in experimental pathology at colorado state university and was the former medical research council postdoctoral fellow and the dr douglas james fellow in the department of pathology at mcgill university             william j gedale william j gedale is a senior advisor and cofounder of ngn capital he has been in the investment business since  mr gedale joined ngn from mount everest advisors which he founded in  he has served as an investment advisor to individuals and as a full time consultant to warburgpincus capital management the worlds largest venture capital firm between  and  in this capacity he initiated the  million dollar financing of zymogenetics he also helped arrange the  million funding by sandoz novartis of the scripps research institute and the  million funding of the neuroscience institute of la jolla california of which he is a trustee before founding mount everest advisors he was a managing director at john w bristol  co in  before this as of  mr gedale was president  chief executive officer of general american investors which he had joined in  he is currently chairman of promosone and vice chairman of enzybiotics he has been a director of gamco gabelli holding general american investors allied clinical laboratories us home health care unilab corporation and bioreliance corporation william gedale holds an mba from new york university a jd from fordham law school and an ab from syracuse university he currently serves on the board of directors of pin pharma and previously served on the board of directors of kika medical inc acquired by merge healthcare and bioarray solutions acquired by immucor     top of page print version   home  about ngn   investment professionals    advisors  news  contact us copyright   ngn capital rights reserved